YOLFTbeta
Nova Leap Health Corp

Nova Leap Health Corp

NLH · V · Healthcare / Medical Care Facilities

0.49CAD-0.01 (-2.00%)

Price History

Full chart

Market Stats

Previous Close0.50
Open0.49
Day Range0.49 – 0.49
52-Week Range0.26 – 0.60
Volume10.58K
Market Cap43.66M
P/E (TTM)25.00
Forward P/E20.49
EPS0.02
Dividend Yield0.00%
Beta1.60
50-Day Avg0.503
200-Day Avg0.3847

About

Nova Leap Health Corp., together with its subsidiaries, provides home-based and community-based healthcare services in the United States and Canada. It offers home and home health care services, including dementia care, companionship, personal and skilled nursing care, respite care, palliative care, care management, cooking and meal preparation, light housekeeping, daily living activities, transportation, medication reminders, and medication administration by nursing staff. The company provides its services through private homes, assisted living communities, hospitals, nursing homes, hospice, and rehabilitation centers. Nova Leap Health Corp. was incorporated in 2015 and is headquartered in Halifax, Canada.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Christopher Donald Dobbin C.A., CPA
  • Employees0
  • Headquarters7071 Bayers Road, Halifax, NS, Canada, B3L 2C2, Canada
  • Websitehttps://novaleaphealth.com

Leadership

  • Mr. Christopher Donald Dobbin C.A., CPACEO, President & Director · b. 1975
  • Mr. Chris LeBlancCompany Secretary & CFO
  • Ms. Melissa AndersonSenior President of Operations (U.S.)

Financials

Income Statement

Currency: USD2016-10-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue14.61K39.99K1.06M10.36M17.40M17.31M21.28M28.21M26.18M25.76M31.47M
Growth (%)-+173.82%+2550.21%+877.71%+67.96%-0.55%+22.93%+32.55%-7.18%-1.60%+22.15%
Cost of Revenue18.64K24.55K693.95K7.04M11.56M11.44M14.07M18.23M16.41M15.87M18.98M
Gross Profit-4.03K15.44K365.90K3.32M5.84M5.87M7.21M9.98M9.77M9.89M12.48M
Gross Margin-27.62%38.61%34.52%32.04%33.58%33.92%33.89%35.37%37.31%38.38%39.67%
Operating Expense353.80K530.68K1.27M2.56M5.96M4.06M3.32M11.07M9.31M9.02M11.38M
Operating Income-357.83K-515.24K-907.15K763.74K-112.83K1.81M3.89M-1.10M460.15K863.71K1.11M
Operating Margin-2450.09%-1288.39%-85.59%7.37%-0.65%10.48%18.30%-3.90%1.76%3.35%3.51%
EBITDA--461.67K-820.71K-321.01K505.84K2.36M4.76M256.39K-336.13K2.50M1.05M
EBITDA Margin--1154.43%-77.44%-3.10%2.91%13.63%22.35%0.91%-1.28%9.71%3.34%
Net Income-405.14K-489.52K-851.61K-961.27K-1.06M1.26M1.76M-835.75K-1.05M1.38M-189.86K
Net Income Margin-2773.97%-1224.07%-80.35%-9.28%-6.07%7.26%8.27%-2.96%-4.03%5.35%-0.60%
Interest Expense03.23K21.84K312.92K460.73K448.12K401.12K270.99K144.75K106.86K349.87K
Interest Expense % of Total Revenue0.00%8.08%2.06%3.02%2.65%2.59%1.89%0.96%0.55%0.41%1.11%

Balance Sheet

Currency: USD2016-10-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets523.22K391.47K2.91M12.46M14.11M17.54M26.77M23.95M20.90M22.39M23.48M
Total Liabilities259.95K246.08K1.09M5.70M7.04M7.69M8.29M5.27M2.70M4.14M4.44M
Total Equity263.28K145.38K1.82M6.76M7.07M9.84M18.48M18.68M18.20M18.25M19.04M
Cash227.16K148.28K136.82K1.28M1.64M2.78M1.73M1.27M894.76K1.40M1.49M
Total Debt-178.28K540.54K4.62M5.71M5.96M6.20M3.97M---
Net Debt-30.00K403.73K3.34M4.08M3.18M4.47M2.69M-138.63K514.11K

Cash Flow

Currency: USD2016-10-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-266.00K-333.31K-628.79K-1.55M613.80K3.01M2.18M1.02M2.15M1.39M1.56M
Investing Cash Flow-261.82K-221.54K-1.80M-6.36M-988.30K-1.56M-7.40M-56.24K---
Financing Cash Flow775.63K721.59K2.42M9.05M731.35K-325.46K4.33M-1.41M-2.52M729.78K-251.07K
Capital Expenditure0019.42K19.42K15.48K6.72K71.24K71.24K27.99K25.00K0
Free Cash Flow--333.31K-628.79K-1.57M598.32K3.01M2.18M949.49K2.13M1.36M1.56M
Dividends Paid--000000000
FCF to OCF-100.00%100.00%101.25%97.48%99.78%100.00%93.02%98.70%98.20%100.00%
Dividend Paid to FCF--0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Earnings

Report DateMar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019May 26, 2020Aug 25, 2020Nov 17, 2020Mar 11, 2021May 6, 2021Aug 5, 2021Nov 4, 2021Mar 10, 2022May 12, 2022Aug 12, 2022Nov 10, 2022Mar 8, 2023May 11, 2023Aug 10, 2023Nov 9, 2023Mar 7, 2024May 9, 2024Nov 7, 2024Nov 5, 2026
EPS Estimate----------------0.000.000.010.02-0.010.000.02--0.00--0.00-
EPS Actual-0.01-0.01-0.02-0.01-0.02-0.00-0.010.00-0.01-0.01-0.00-0.010.01-0.020.010.020.010.010.03-0.01-0.01-0.000.01-0.01-0.00-0.000.00-0.010.01-0.00-
Surprise------------------200.00%-150.00%--104.00%--150.00%-------
Timing------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap43.66M
Enterprise Value51.38M
Trailing P/E25.00
Forward P/E20.49
Price / Sales1.30
Price / Book1.73
EPS0.02
Book Value0.3161
Revenue (TTM)33.60M
Gross Profit (TTM)13.41M
EBITDA2.14M
Profit Margin4.01%
Operating Margin8.03%
Return on Equity7.07%
Return on Assets4.37%
Shares Outstanding87.31M
Shares Float50.00M
Beta1.60
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%